Prilosec OTC Exceeds Sales Expectations, Drags Down Healthcare Earnings
This article was originally published in The Tan Sheet
Executive Summary
Prilosec OTC sales have been a boon to Procter & Gamble's healthcare top line, but the product's successful launch has negatively impacted earnings a year after its debut